These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 14732308)
1. In vitro activity of ABT773, a new ketolide derivative exhibiting innovative microbiological properties against well-characterised antibiotic resistant pathogens in Italy. Bozzolasco M; Debbia EA; Roveta S; Schito AM; Marchese A Int J Antimicrob Agents; 2004 Jan; 23(1):11-6. PubMed ID: 14732308 [TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Jamjian C; Biedenbach DJ; Jones RN Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207 [TBL] [Abstract][Full Text] [Related]
3. The in vitro activity of ABT773, a new ketolide antimicrobial agent. Andrews JM; Weller TM; Ashby JP; Walker RM; Wise R J Antimicrob Chemother; 2000 Dec; 46(6):1017-22. PubMed ID: 11102425 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of RU-66647, a new ketolide. Jones RN; Biedenbach DJ Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099 [TBL] [Abstract][Full Text] [Related]
5. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents. Peric M; Browne FA; Jacobs MR; Appelbaum PC Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria. Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM Antimicrob Agents Chemother; 1997 May; 41(5):1196-202. PubMed ID: 9145901 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004). Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511 [TBL] [Abstract][Full Text] [Related]
8. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria. Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805 [TBL] [Abstract][Full Text] [Related]
9. Microbiological profile of telithromycin, the first ketolide antimicrobial. Felmingham D Clin Microbiol Infect; 2001; 7 Suppl 3():2-10. PubMed ID: 11523558 [TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of rokitamycin compared with that of other macrolides. Yu KW; Briones F; Chin NX; Neu HC Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182 [TBL] [Abstract][Full Text] [Related]
11. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007. Dowzicky MJ; Park CH Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792 [TBL] [Abstract][Full Text] [Related]
12. Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens. Fluit AC; Schmitz FJ; Verhoef J; Int J Antimicrob Agents; 2001 Aug; 18(2):147-60. PubMed ID: 11516938 [TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases. Biedenbach DJ; Beach ML; Jones RN Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007. Garrison MW; Mutters R; Dowzicky MJ Diagn Microbiol Infect Dis; 2009 Nov; 65(3):288-99. PubMed ID: 19733459 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae. Walsh F; Carnegy F; Willcock J; Amyes S J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640 [TBL] [Abstract][Full Text] [Related]
16. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus. Jones ME Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372 [TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria. Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates. Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren. Tempera G; Furneri PM; Carlone NA; Cocuzza C; Rigoli R; Musumeci R; Pilloni AP; Prenna M; Tufano MA; Tullio V; Vitali LA; Nicoletti G J Chemother; 2010 Jun; 22(3):153-9. PubMed ID: 20566418 [TBL] [Abstract][Full Text] [Related]
20. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics. Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]